(:SPEX)

Oct 03, 2022 09:00 am ET
AIkido Pharma Continues Share Repurchase Program
NEW YORK, Oct. 3, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on the $3 million share repurchase program (the "Share Repurchase Program") authorized by the Company's Board of Directors on January 21, 2022.
Feb 03, 2021 08:00 am ET
AIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to Scientific Advisory Board
NEW YORK, Feb. 3, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that Dr. Scott T. Tagawa, M.D., M.S., FACP, a Professor of Medicine and Urology at Weill Cornell Medicine and an Attending Physician at New York-Presbyterian-Weill Cornell Medical Center, has joined the Company's Scientific Advisory Board.
Feb 01, 2021 07:00 am ET
Aikido Pharma Secures Early Interest in Next Generation Radiotherapy
NEW YORK, Feb. 1, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company executed a Two Million Dollar Convertible Promissory Note Purchase Agreement with Convergent Therapeutics, Inc., securing an early investment in Convergent. Convergent has exclusive rights to technology related to next generation radiopharmaceutical therapy for prostate cancer that is covered by multiple issued U.S. and foreign patents.
Oct 21, 2019 08:30 am ET
Spherix Issues Update to Shareholders
NEW YORK, Oct. 21, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) President and CEO, Anthony Hayes, today released a letter to shareholders outlining the Company's plans for its previously disclosed dividend distribution.
Oct 17, 2019 08:30 am ET
Spherix Highlights ValuEngine Upgrade to 'Buy' Rating
NEW YORK, Oct. 17, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced that its stock has been upgraded to a "buy" rating from a "hold" rating in a research note issued to investors by ValuEngine Inc. (www.valuengine.com). ValuEngine uses proprietary models to forecast and value individual equities across a diverse set of industries.
Oct 16, 2019 11:13 am ET
Emerging Markets Report: In the Money
It is not often in the pages of the Emerging Markets Report do we get the opportunity to tell our readers that a Company is giving back roughly $425,000* worth of value to its shareholders. In fact, we never have. But that’s precisely what Spherix...
Oct 11, 2019 02:15 pm ET
Spherix Sets Record Date for Dividend Distribution
NEW YORK, Oct. 11, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced that on October 2, 2019, the Board of Directors of Spherix Incorporated ("Spherix") approved a distribution to Spherix stockholders of 100,000 shares of Hoth Therapeutics, Inc. ("Hoth") held by Spherix.
Oct 02, 2019 07:00 am ET
Emerging Markets Report: Botox, Anthrax, and the Healing Power of Poison
When Botox hit the annals of pop culture as a beauty product, a healer, and more it was shocking to many. How could a product derived from the notorious toxin Clostridium botulinum, the stuff that causes botulism, serve the greater good?  Until...
Oct 01, 2019 10:30 am ET
Spherix Issues Update to Shareholders
NEW YORK, Oct. 1, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) President and CEO, Anthony Hayes, today released a letter to shareholders.
Sep 25, 2019 01:30 pm ET
Spherix Issues Update to Shareholders Regarding Planned Dividend Distribution
NEW YORK, Sept. 25, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) President and CEO, Anthony Hayes, today released a letter to shareholders outlining the Company's plans for its previously disclosed dividend distribution.
Sep 17, 2019 01:30 pm ET
University of Maryland, Baltimore Grants Spherix Exclusive Option to License Anthrax Based Ovarian Cancer Drug PrAg-PAS
NEW YORK, Sept. 17, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced that the Company has executed an exclusive option agreement ("Option") with the University of Maryland, Baltimore (UMB) related to its anticancer drug designated PrAg-PAS, a novel protein drug designed by re-engineering the anthrax toxin delivery mechanism so that any one of a number of anticancer drug payloads may be specifically transported into ovarian cancer cells. 
Sep 11, 2019 01:00 pm ET
Spherix is Granted Exclusive Option to License Anticancer Drug from the University of Kentucky
NEW YORK, Sept. 11, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced that the Company has executed an exclusive option agreement ("Option") with the University of Kentucky (UK) related to its anticancer drug designated G4-1, a novel proteasome inhibitor.
Sep 09, 2019 08:00 am ET
Spherix Announces Results of Special Meeting of Shareholders
NEW YORK, Sept. 9, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced results from the Special Meeting of Shareholders held on September 5th (the "Meeting").
Aug 19, 2019 08:00 am ET
Spherix Urges Shareholders to Approve Purchase of CBM BioPharma, Inc. Assets at Special Meeting
NEW YORK, Aug. 19, 2019 /PRNewswire/ -- Spherix Incorporated, (NASDAQ: SPEX) a technology development company committed to the fostering of innovative ideas, today issued a letter to shareholders:
Jun 11, 2019 10:10 am ET
Spherix Inc. (NasdaqCM: SPEX) Trading Below Book Value; Diversified Asset Base Adds Value
Spherix's investment portfolio into emerging biotech stocks has resulted in substantial gains, turning a roughly $860,000 investment into a position worth more than $11 million at current share price levels, and marking a Price to Book ratio of less than 100%; The recently announced asset-purchase agreement of CBM BioPharma extends pipeline promise
Jun 06, 2019 09:00 am ET
StockLab Reports: By the Numbers
LAS VEGAS, NV / ACCESSWIRE / June 6, 2019 / In October of last year, StockLab's editorial team was introduced to Spherix Incorporated (NASDAQ: SPEX). We were immediately intrigued by some of the medical advancements in Spherix's universe which were, well, let's just say fascinating to say the least. If you haven't read our firsteditorial, here's the link.
May 16, 2019 08:00 am ET
Spherix Reports First Quarter 2019 Results of $11,937,000 in Assets and $982,000 in Liabilities
NEW YORK, May 16, 2019 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) ("Spherix" or the "Company") today announced that the Company filed its Form-10Q for the period ended March 31, 2019, which showed total assets of $11,937,000.00 and liabilities of $982,000.00, with 2,010,074 shares of common stock outstanding. 
Apr 02, 2019 08:00 am ET
Spherix Issues Letter to Shareholders
NEW YORK, April 2, 2019 /PRNewswire/ -- Spherix Incorporated, (NASDAQ: SPEX) a technology development company committed to the fostering of innovative ideas, today issued a letter to shareholders:
Mar 12, 2019 08:00 am ET
Spherix Announces Filing of its Annual Report on Form 10-K, Records $7.5 Million One Time Gain
NEW YORK, March 12, 2019 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX)- a technology development company committed to the fostering of innovative ideas, announced today that it has filed its Annual Report on Form 10-K for the year ended December 31, 2018 with the Securities and Exchange Commission.
Nov 27, 2018 07:00 am ET
Spherix Announces Preclinical Pancreatic Cancer Treatment Study Moving Forward
NEW YORK, Nov. 27, 2018 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced the funding of a study for KPC34, for pancreatic cancer, specifically pancreatic ductal adenocarcinoma (PDA).  PDA is considered the deadliest of major cancers and patients are in desperate need of improved therapies. Other than lung cancer, PDA is projected to kill more people than any other malignancy by the year 2030. 
Nov 26, 2018 07:20 am ET
Spherix Announces Ownership Interest in Electric Scooter Business
NEW YORK, Nov. 26, 2018 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced it has secured an ownership interest in Mellow Scooters, LLC, a leading-edge company that enables anyone to own and operate a personal fleet of electric scooters and dockless bicycles to generate revenue. 
Oct 29, 2018 08:00 am ET
Spherix Announces the Addition of Dr. Rana Quraishi to Company's Advisory Board
NEW YORK, Oct. 29, 2018 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced that it has added Dr. Rana Quraishi to the Company's Advisory Board to assist the Company in evaluating potential opportunities in the biopharmaceutical area.
Oct 25, 2018 03:12 pm ET
StockLab Reports: Of Mice and Men
Las Vegas, Nevada--(Newsfile Corp. - October 25, 2018) - Early stage biotechnology and pharmaceutical companies often present a quandary for investors. The technology is generally difficult to understand and investors just can't fully picture the potential.
Oct 17, 2018 08:00 am ET
Spherix Provides Video Demonstration of CBM Drug Reversing Paralysis in Preclinical Study
NEW YORK, Oct. 17, 2018 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today provided shareholders with a video demonstration on its website of the potential effectiveness of CBM BioPharma, Inc.'s ("CBM) innovative drug platform.   As previously disclosed on October 11, 2018, Spherix entered into a merger agreement with CBM, a privately held innovative pharmaceutical company focused on the development of drugs in the multibillion-dollar oncology therapeutics market.  The notable video, which was recorded at Wake Forest University, visually demonstrates the potential effectiveness of one
Oct 11, 2018 08:00 am ET
Spherix to Merge with CBM BioPharma Pharmaceutical Company
NEW YORK, Oct. 11, 2018 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced that it has entered into a merger agreement with CBM BioPharma, Inc. ("CBM") that will transform Spherix into an innovative pharmaceutical company with pioneering drugs and treatments focused on the multibillion dollar oncology therapeutics market.
Aug 15, 2018 07:30 am ET
Spherix Announces Strategic Equity Investment in DatChat in Lieu of Full Company Merger
NEW YORK, Aug. 15, 2018 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) a technology development company committed to the fostering of innovation and monetization of intellectual property, today announced it has terminated its merger agreement with DatChat. After strategic meetings with DatChat, both organziations believe there is a more effective strategy that will have the best opportunity for long-term growth.
May 16, 2018 08:00 am ET
Spherix and DatChat Announce New User Interface and New Features for DatChat App
NEW YORK, May 16, 2018 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX), a technology company committed to advancing innovation by participation in the development of new technology, today announced the release of a new IOS user interface and advanced technological features for DatChat. 
May 08, 2018 08:00 am ET
Spherix CEO, Anthony Hayes, Set to Appear Live on Cheddar TV Interview to Take Place From the Floor of the NYSE on May 9th 12:50 p.m.
NEW YORK, May 8, 2018 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX), a technology company committed to advancing innovation by participation in the development of new technology, today announced that its CEO, Anthony Hayes is scheduled to appear live on Cheddar TV (www.cheddar.com) on May 9th at 12:50 p.m.
May 07, 2018 08:00 am ET
Spherix Announces Adjustment to DatChat Acquisition Consideration
NEW YORK, May 7, 2018 /PRNewswire/ -- Spherix Inc. (NASDAQ: SPEX) ("Spherix" or the "Company"), today announced that the Company has negotiated amended terms of the pending acquisition of DatChat Inc., an encrypted personal privacy platform, focused on encrypted communication, internet privacy and digital rights management.
Apr 11, 2018 08:00 am ET
Spherix Highlights Size of Multi-Billion Dollar Mobile Messaging Sector
NEW YORK, April 11, 2018 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) a technology company committed to advancing innovation by participation in the development of new technology, today provided an update on the overall size and scope of the $3 billion mobile instant messaging market in which the company intends to operate following the proposed acquisition of DatChat Inc. (www.datchat.com) 
Apr 04, 2018 08:00 am ET
Spherix Issues Letter to Shareholders
NEW YORK, April 4, 2018 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) a technology company committed to advancing innovation by participation in the development of new technology, today issued a letter to shareholders:
Mar 27, 2018 08:00 am ET
Spherix Expands Blockchain Investment
NEW YORK, March 27, 2018 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) announced today that the Company has closed an investment in TheBit Daily LLC ("TheBit"), a development stage media and education platform focused on the blockchain and cryptocurrency space.  The site provides strategic and intelligently condensed insight to this exciting technology.  For more information, please visit: www.thebitdaily.com.
Mar 19, 2018 08:00 am ET
DatChat Issues Shareholder Update on Spherix Merger and Blockchain Development.
NEW BRUNSWICK, N.J., March 19, 2018 /PRNewswire/ -- DatChat Incorporated ("DatChat"), an encrypted personal privacy platform, focused on encrypted communication, internet privacy and digital rights management, today updated shareholders on its merger agreement with Spherix Incorporated (NASDAQ: SPEX), its continued blockchain development and mining efforts.
Mar 15, 2018 09:00 am ET
Spherix Announces Pricing of $3 Million Public Offering of Common Stock
NEW YORK, March 15, 2018 /PRNewswire/ -- Spherix Incorporated (SPEX), a technology development company committed to the fostering of innovation and monetization of intellectual property, today announced that it has priced a registered public offering on a "best efforts" basis of an aggregate of 2,222,222 shares of common stock at a price to the public of $1.35 per share.  The offering is expected to close on or about March 19, 2018, subject to the satisfaction of customary closing conditions.
Mar 14, 2018 04:30 pm ET
Spherix Announces Proposed Public Offering of Common Stock
NEW YORK, March 14, 2018 /PRNewswire/ -- Spherix Incorporated (SPEX), a technology development company committed to the fostering of innovation and monetization of intellectual property, today announced a proposed registered public offering of its common stock. The offering is being made on a "best efforts" basis and subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Mar 13, 2018 08:00 am ET
Spherix To Enter Cyber Security Market via DatChat Acquisition
NEW YORK, March 13, 2018 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) a technology development company committed to the fostering of innovation and monetization of intellectual property, today announced that it has entered into a definitive purchase agreement to acquire 100% ownership of DatChat Inc. DatChat is a privately held personal privacy platform, focused on Encrypted Communication, Internet Security and Digital Rights Management.
Feb 22, 2018 07:00 am ET
Hoth Therapeutics Inc. Announces Completion of Series A Financing
NEW YORK, Feb. 22, 2018 /PRNewswire/ -- Hoth Therapeutics Inc. ("Hoth" or the "Company"), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema, announced today that it has completed its Series A financing totaling $3 million, before expenses, to fund operations and advance Hoth's BioLexa Platform.  Laidlaw & Co (UK) Ltd. ("Laidlaw") in New York served as the sole placement agent.
Dec 13, 2017 07:00 am ET
Spherix Holds Annual Shareholder Meeting
NEW YORK, Dec. 13, 2017 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) a technology development company committed to the fostering of innovative ideas, today announced that it held its Annual Shareholder Meeting.
Nov 08, 2017 08:00 am ET
Spherix Announces Sponsorship of Student-Led Artificial Intelligence and Super Computing Initiative
NEW YORK, Nov. 8, 2017 /PRNewswire/ -- Spherix Incorporated ("Spherix" or the "Company") (NASDAQ: SPEX), a technology development company committed to the fostering of innovative ideas, today announced the sponsorship of the Shark Tank initiative at the College of William & Mary in Virginia.  William & Mary is a cutting-edge research university and is the second-oldest institution of higher education in the United States.
Oct 16, 2017 09:00 am ET
Hoth Therapeutics Inc. Announces the Addition of Dr. Richard D Granstein, M.D. to the Company's Technology Advisory Board
NEW YORK, Oct. 16, 2017 /PRNewswire/ -- Hoth Therapeutics Inc., a Nevada corporation ("Hoth" or  the "Company"), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema, announced today the addition of Dr. Richard D. Granstein, M.D., to the Company's Technology Advisory Board.  The Technology Advisory Board was formed to assist the Company in developing the BioLexa Platform.  The BioLexa Platform is a proprietary, patented, drug compound platform developed at the University o
Sep 05, 2017 09:00 am ET
Hoth Therapeutics Inc. Announces the Addition of Dr. Andrew Herr to the Company's Technology Advisory Board
NEW YORK, Sept. 5, 2017 /PRNewswire/ -- Hoth Therapeutics Inc., a Nevada corporation ("Hoth" or the "Company"), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema, announced today the addition of Dr. Andrew Herr, PhD, to the Company's Technology Advisory Board.  The Technology Advisory Board was formed to assist the Company in developing the BioLexa Platform.  The BioLexa Platform is a proprietary, patented, drug compound platform developed at the University of Cincinnat
Aug 15, 2017 09:00 am ET
Spherix Announces the Addition of Dr. Scott T. Tagawa to Company's Technology Advisory Board
NEW YORK, Aug. 15, 2017 /PRNewswire/ -- Spherix Incorporated ("Spherix" or the "Company") (NASDAQ: SPEX), an intellectual property development company committed to the fostering of technology, today announced the addition of Dr. Scott T. Tagawa to the Company's Technology Advisory Board.  The Technology Advisory Board was formed to assist the Company in evaluating potential opportunities in the biopharmaceutical arena.
Aug 02, 2017 09:00 am ET
Spherix Issues Letter to Shareholders
NEW YORK, Aug. 2, 2017 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) an intellectual property development company committed to fostering of technology, today issued a letter to shareholders.
Jul 27, 2017 08:30 am ET
Spherix Announces That Anthony Hayes Joins the Board of Directors at Hoth Therapeutics Inc.
NEW YORK, July 27, 2017 /PRNewswire/ -- Spherix Incorporated ("Spherix" or the "Company") (NASDAQ: SPEX), an intellectual property development company committed to fostering of technology, today announced that Anthony Hayes, CEO of Spherix Inc., joins the board of directors at Hoth Therapeutics Inc.
Jul 25, 2017 09:00 am ET
Spherix Announces the Formation of a Technology Advisory Board in Area of BioPharmaceutical Opportunities
NEW YORK, July 25, 2017 /PRNewswire/ -- Spherix Incorporated ("Spherix" or the "Company") (NASDAQ: SPEX), an intellectual property development company committed to the fostering of technology, today announced the formation of a Technology Advisory Board in the area of biopharmaceutical opportunities.
Jul 24, 2017 05:15 pm ET
Spherix Announces Closing Of Public Offering Of Common Stock
NEW YORK, July 24, 2017 /PRNewswire/ -- Spherix Incorporated ("Spherix" or the "Company") (NASDAQ: SPEX), an intellectual property development company committed to fostering of technology, today announced that it has closed its previously announced firm commitment underwritten public offering of 1,250,000 shares of its common stock at a price to the public of $2.00 per share.
Jul 19, 2017 09:00 am ET
Spherix Announces Pricing of Public Offering of Common Stock
NEW YORK, July 19, 2017 /PRNewswire/ -- Spherix Incorporated ("Spherix" or the "Company") (NASDAQ: SPEX), an intellectual property development company committed to fostering of technology and monetization of intellectual property, today announced that it has priced a firm commitment underwritten public offering of 1,250,000 shares of its common stock at a price to the public of $2.00 per share. In addition, Spherix has granted the underwriter a 45-day option to purchase up to 187,500 additional shares of common stock to cover over-allotments, if any. The offering is expected to close on or a
Jul 03, 2017 09:00 am ET
Spherix Inc. Announces Closing of the Deal with Hoth Therapeutics
NEW YORK, July 3, 2017 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) reported today, following the disclosure made June 20th 2017, that the Company has closed the transaction with Hoth Therapeutics.  Hoth Therapeutics is a development stage biopharmaceutical company focused on the development of therapeutics for patients suffering from atopic dermatitis, such as eczema.   
Jun 27, 2017 09:00 am ET
Spherix Issues Letter to Shareholders
NEW YORK, June 27, 2017 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) an intellectual property development company committed to the fostering of technology and monetization of intellectual property, today issued a letter to shareholders.
Apr 19, 2017 09:00 am ET
Spherix Announces Economic Interest Acquired in New Patent Portfolio
NEW YORK, April 19, 2017 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) an intellectual property development company committed to the fostering of technology and monetization of intellectual property, today announced that it has acquired an economic interest in a new patent portfolio that is largely unlicensed to any third party. 
Feb 21, 2017 08:00 am ET
Spherix Announces New Clients in the $100B Online Learning Business
NEW YORK, Feb. 21, 2017 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) an intellectual property development company committed to the fostering of technology and monetization of intellectual property, today announced that it has signed up a new client to its Patent Monetization and Consulting subsidiary.
Jan 23, 2017 08:00 am ET
Spherix Updates Shareholders
NEW YORK, Jan. 23, 2017 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) an intellectual property development company committed to the fostering of technology and monetization of intellectual property, today provided an update on its active patent infringement lawsuits.
Dec 05, 2016 08:00 am ET
New Patent Infringement Lawsuit Filed Against Alcatel-Lucent Under Spherix Collaboration Agreement
NEW YORK, Dec. 5, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) an intellectual property development company committed to the fostering and monetization of intellectual property and the advancement of technology, today announced that as part of its previously announced collaboration with Equitable IP Holdings LLC ("Equitable" and the "Equitable IP Program"), Equitable has filed an additional lawsuit for the infringement of valuable patent assets formerly owned by Nortel Networks.
Nov 28, 2016 08:00 am ET
Spherix Executes Revenue Generating Agreement with LawCash
NEW YORK, Nov. 28, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX)  a company committed to the fostering of technology and monetization of intellectual property, today announced that it executed a Consulting Services Agreement with LawCash ®(www.lawcash.com), ("LawCash") one of the nation's largest pre-settlement funding companies.  Under the Consulting Services Agreement, Spherix will provide LawCash with consulting and managerial services, with the goal of growing both businesses, as well as exploring other opportunities for the two companies to work together.
Nov 07, 2016 08:00 am ET
Spherix Signs New Client in the $3.5 Billion Vaporizer Business
NEW YORK, Nov. 7, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) an intellectual property development company committed to the fostering of technology and monetization of intellectual property, today announced that its IP consulting subsidiary has signed a Patent Monetization and Consulting Agreement (the "Agreement) with Vapir Enterprises, Inc., (ticker: VAPI), a patent rich company in the $3.5B vapor space.  Under the Agreement, Spherix will conduct a detailed review of Vapir's patent portfolio and develop a monetization program for Vapir.
Oct 31, 2016 09:30 am ET
Spherix Announces Changes to Board of Directors
NEW YORK, Oct. 31, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) an intellectual property development company committed to the fostering of technology and monetization of intellectual property, today announced that two of the Company's Directors, Jeffrey Ballabon and Howard E. Goldberg, have stepped down from the Spherix Board, effective immediately. Both Mr. Ballabon and Mr. Goldberg resigned amicably and expressed no disagreements on any of the Company's principles or practices.
Oct 19, 2016 09:00 am ET
Spherix Launches New Patent Licensing Initiative
NEW YORK, Oct. 19, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) an intellectual property development company committed to the fostering of technology and monetization of intellectual property, today announced the formation of Spherix Management Services, Inc., a wholly owned subsidiary focused on helping inventors and small companies manage their IP monetization programs.
Oct 17, 2016 09:00 am ET
Spherix Provides Update on Patent Infringement Litigation
NEW YORK, Oct. 17, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) an intellectual property development company committed to the fostering of technology and monetization of intellectual property, today provided an update on its active patent infringement lawsuits, new lawsuits filed, and spending reduction initiatives.
Sep 14, 2016 09:00 am ET
Spherix Issues Letter to Shareholders
NEW YORK, Sept. 14, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) an intellectual property development company committed to the fostering of technology and monetization of intellectual property, today issued a letter to shareholders.
Aug 18, 2016 09:00 am ET
Spherix Monetization Program Continues to Expand
NEW YORK, Aug. 18, 2016 /PRNewswire/ Spherix Incorporated (Nasdaq: SPEX) an intellectual property development company committed to the fostering of technology and monetization of intellectual property, today announced that Equitable IP Holdings LLC ("Equitable" or the "Equitable IP Program"), has filed another patent infringement lawsuit, bringing the total of new suits on file to seven.  
Aug 17, 2016 09:00 am ET
Spherix Continues to Expand Monetization Program
NEW YORK, Aug. 17, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) an intellectual property development company committed to the fostering and monetization of intellectual property and the advancement of technology, today announced that Equitable IP Holdings LLC ("Equitable" or the "Equitable IP Program"), has filed two additional patent infringement lawsuits on the patents Spherix acquired from Rockstar.
Aug 16, 2016 09:00 am ET
Equitable IP Files Three Patent Infringement Lawsuits Asserting Standard Essential Patents Advancing Spherix Monetization Program
NEW YORK, Aug. 16, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) an intellectual property development company committed to the fostering and monetization of intellectual property and the advancement of technology, today announced that as part of its previously announced collaboration with Equitable IP Holdings LLC ("Equitable" or the "Equitable IP Program"), Equitable has filed three additional lawsuits for the infringement of valuable patent assets formerly owned by Nortel Networks.
Aug 09, 2016 09:00 am ET
Spherix Enters Into Non-Binding Letter Of Intent with Privacy Messaging Pioneer DatChat
NEW YORK, Aug. 9, 2016 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) –a company committed to the fostering of technology and the monetization of intellectual property, today announced that it has entered into a non-binding letter of intent ("LOI") to invest in DatChat Inc. – a pioneer in the secure (privacy) messaging industry – in exchange for an equity security interest in DatChat.  DatChat's patent-pending encryption technology allows users to secure their messages sent between mobile devices.  Earlier this year, DatChat announced that its technology offers an unprecedented level of
Aug 08, 2016 01:00 pm ET
Spherix Issues Shareholder Update
NEW YORK, Aug. 8, 2016 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) – a company committed to the fostering of technology and the monetization of intellectual property, today issued an update commenting on recent events.  The Company said:
Aug 08, 2016 12:00 pm ET
Spherix Announces Closing of Underwritten Public Offering of Common Stock
NEW YORK, Aug. 8, 2016 /PRNewswire/ -- Spherix Incorporated ("Spherix") (NASDAQ: SPEX) an intellectual property development company committed to the fostering and monetization of intellectual property, today announced the closing of the previously announced firm commitment underwritten public offering of 1,592,357 shares of its common stock at a fixed price to the public of $1.57.  The gross proceeds to Spherix from this offering are $2,500,000, before deducting the underwriting discount and other estimated offering expenses payable by the Company.  Spherix has granted the representative of
Aug 03, 2016 10:38 am ET
Spherix Announces Pricing of Underwritten Public Offering of Common Stock
NEW YORK, Aug. 3, 2016 /PRNewswire/ -- Spherix Incorporated ("Spherix") (NASDAQ: SPEX) an intellectual property development company committed to the fostering and monetization of intellectual property, today announced the pricing of a firm commitment underwritten public offering of up to 1,592,357 shares of its common stock at a fixed price to the public of $1.57.  The gross proceeds to Spherix from this offering are expected to be $2,500,000, before deducting the underwriting discount and other estimated offering expenses payable by the Company.  The offering is expected to close on or abou
Jun 14, 2016 09:00 am ET
Spherix Comments on Recent Supreme Court Decision and Proposed Billion Dollar Yahoo Inc. Patent Sale
NEW YORK, June 14, 2016 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) – a company committed to the fostering of technology and the monetization of intellectual property, today commented on recent positive developments in the patent monetization space.
Jun 01, 2016 09:00 am ET
Spherix Featured in International Patent Publication
NEW YORK, June 1, 2016 /PRNewswire/ -- Spherix Incorporated (SPEX) –a company committed to the fostering of technology and the monetization of intellectual property, today announced the Company was featured in a story published in IAM, a publication universally acknowledged as the world's leading IP business media platform.
May 25, 2016 09:00 am ET
Spherix Releases Update Letter to Shareholders
NEW YORK, May 25, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property and the advancement of technology, released a letter to shareholders. The text of the letter is below:
May 24, 2016 09:00 am ET
Spherix Executes Second License Agreement with RPX Corporation
NEW YORK, May 24, 2016 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) – an intellectual property development company committed to the fostering and monetization of intellectual property, today announced a second licensing agreement with RPX Corporation (NASDAQ: RPXC).
May 06, 2016 10:53 am ET
CEOLIVE.TV Announces New Interview With Anthony Hayes, CEO of Spherix, Inc.
CEOLIVE, Inc., a provider of in-depth video interviews with public company CEO's (www.ceolive.tv), announced today that a new interview with Anthony Hayes, President and CEO of Spherix, Inc. (NASDAQ: SPEX), is now available on their website.
Apr 28, 2016 09:00 am ET
Spherix Files Complaint for Patent Infringement Against Level 3 Communications, TW Telecom, and Fairpoint Communications Inc.
NEW YORK, April 28, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property and the advancement of technology, today announced that the Company has filed two lawsuits for the infringement of intellectual property formerly owned by Nortel Networks.  The cases were filed in the U.S. District Court for the District of Delaware against Level 3 Communications, TW Telecom and Fairpoint Communications Inc.  The infringement claims relate to U.S. Patent No. RE40,999 ("the '999 patent
Apr 27, 2016 02:10 pm ET
Spherix Encouraged By U.S. Supreme Court Hearing on Patent Challenges
NEW YORK, April 27, 2016 /PRNewswire/ -- Spherix Incorporated (SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property and the advancement of technology, today announced that the United States Supreme Court recently heard oral arguments in Cuozza Speed Technologies vs. Lee, the first case of its kind where the Supreme Court has remarked on post grant administrative proceedings for challenging issued patents. The Supreme Court is addressing two questions. The first pertains to claim construction standards and whether the Unite
Mar 22, 2016 09:30 am ET
Spherix Regains Compliance with Nasdaq Listing Requirements
NEW YORK, March 22, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property and the advancement of technology, today announced it received formal notification from The Nasdaq Stock Market that the Company has regained compliance with the minimum bid price requirement pursuant to the continued listing standards of Nasdaq.
Mar 15, 2016 09:30 am ET
Spherix Executes Joint Venture Agreement
NEW YORK, March 15, 2016 /PRNewswire/ -- Spherix Incorporated (SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property and the advancement of technology, today announced that the Company had executed an additional agreement to monetize the Nortel patents with Equitable IP Corporation ("Equitable"), a leading patent enforcement and monetization fund.
Mar 11, 2016 08:50 am ET
Spherix Chief Executive Officer to Speak at Industry Conference
BETHESDA, Md., March 11, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property and the advancement of technology, today announced that Anthony Hayes, Chief Executive Officer of Spherix, will speak at the second annual NPE conference. The conference is held at the Covene Event Center in the Financial District of New York City on March 22, 2016.
Mar 08, 2016 09:00 am ET
Spherix Announces Collaborative Agreement To Monetize Patents
BETHESDA, Md., March 8, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property and the advancement of technology, today provided an update on the Company's monetization efforts and announced a collaboration agreement with Equitable IP Corporation ("Equitable"), a leading patent enforcement and monetization fund.
Mar 07, 2016 10:15 am ET
Spherix Releases Update Letter to Shareholders
BETHESDA, Md., March 7, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property and the advancement of technology, released a letter to shareholders. The text of the letter is below:
Feb 29, 2016 07:00 am ET
Spherix Moves to Maintain NASDAQ Compliance as Shareholders Approve Reverse Split
NEW YORK, Feb. 29, 2016 /PRNewswire/ Spherix Incorporated (NASDAQ: SPEX) an intellectual property development company committed to the fostering and monetization of intellectual property, today announced the results of its Special Meeting of stockholders scheduled for February 22, 2016 and adjourned to February 26, 2016.
Feb 22, 2016 05:30 pm ET
Spherix Announces Adjournment of Special Meeting
NEW YORK, Feb. 22, 2016 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEX) an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that its Special Meeting of Stockholders scheduled for and convened on February 22, 2016, was adjourned.
Feb 04, 2016 06:00 am ET
VTech/Uniden Cases to Get Underway
BETHESDA, Md., Feb. 4, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property, today provided an update on the Company's cases against VTech and Uniden in the Northern District of Texas and announcing that those litigations are moving forward. 
Jan 20, 2016 08:00 am ET
Spherix Releases Update Letter to Shareholders
BETHESDA, Md., Jan. 20, 2016 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) -- an intellectual property development company committed to the fostering and monetization of intellectual property, today released a letter to shareholders. The text of the letter is below:

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.